GlassScriptPhysician profile
Ross A Lumsden
NPI 1063704823
$11,214.54
in general payments reported to CMS, 2019-2025
41 companies · $293 in 2025
The $293 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,172 · 2020: $2,533 · 2021: $1,282 · 2022: $1,430 · 2023: $1,043 · 2024: $462 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,777 · Education: $21.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,776.94 |
| Education | $21.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,547.12 | 2019-2025 | Wavewriter Alpha Prime 16, Infinion 16, Coveredge 32 |
| Medtronic USA, INC. | $1,391.14 | 2019 | |
| Scilex Pharmaceuticals INC. | $499.22 | 2019-2023 | Ztlido |
| Collegium Pharmaceutical, INC. | $340.65 | 2019-2023 | Xtampza |
| Medtronic, INC. | $310.40 | 2021-2024 | Intellis Adaptivestim |
| Vertos Medical, INC. | $243.93 | 2019-2023 | Mild Device Kit |
| Assertio Therapeutics, INC. | $225.75 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $208.54 | 2019-2022 | |
| Allergan, INC. | $169.41 | 2019-2022 | |
| Almatica Pharma LLC | $167.93 | 2021-2022 | |
| Abbott Laboratories | $163.44 | 2021-2025 | Proclaim |
| Biodelivery Sciences International, INC. | $156.38 | 2019-2021 | |
| Nevro Corp. | $155.31 | 2019-2023 | Senza |
| Forte Bio-Pharma LLC | $145.35 | 2020-2023 | Prolate, Nalocet |
| Novartis Pharmaceuticals Corporation | $139.60 | 2019 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ross Lumsden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.